Aaron Gerlach

Aaron Gerlach has extensive experience in the pharmaceutical industry, with a focus on drug discovery alliances and business development. Aaron is currently serving as the Director of Drug Discovery Alliances at OmniAb, Inc. since November 2022. Previously, they held the same role at Icagen from 2015 to 2021, where they also served as the Director of Business Development. In these positions, they led high-profile multi-site drug discovery projects and teams, and was responsible for growing the business through strategic partnerships and revenue-generating contracts. Aaron also has experience in academia, serving as a Scientific Advisory Board Member for the Pitt Hopkins Research Foundation since 2017. Before that, they worked at Pfizer as a Senior Principal Scientist from 2011 to 2015, leading pre-IND small molecule drug discovery projects and managing and training scientists. Prior to Pfizer, they held various roles at Icagen from 2003 to 2011, including Senior Research Investigator and Senior Research Scientist, where they led a successful epilepsy project and served as a member of the clinical team.

Aaron Gerlach's education history is as follows:

From 1989 to 1993, they attended Ohio University and obtained a Bachelor of Science degree in Biological Sciences.

In 1992, they completed an internship in Neuroscience at Mayo Clinic Alix School of Medicine.

Aaron then attended the University of Alabama at Birmingham from 1993 to 1995, focusing on Neuroscience.

From 1995 to 2000, they pursued a Ph.D. in Cell Biology and Physiology at the University of Pittsburgh.

Finally, from 2000 to 2003, they participated in a Postdoctoral Fellowship at Oregon Health & Science University's Vollum Institute.